Xin Zou Selected Research

Xin Zou Research Topics

Disease

18	Insulin Resistance 01/2022 - 03/2005
12	Neoplasms (Cancer) 04/2022 - 12/2013
11	Inflammation (Inflammations) 01/2022 - 02/2016
9	Type 2 Diabetes Mellitus (MODY) 03/2021 - 08/2011
8	Body Weight (Weight, Body) 04/2022 - 03/2005
4	Diabetes Mellitus 01/2022 - 07/2013
4	Obesity 01/2021 - 03/2017
4	Sleep Deprivation 03/2020 - 03/2017
4	Hyperlipidemias (Hyperlipidemia) 01/2017 - 01/2013
3	Stomach Neoplasms (Stomach Cancer) 04/2022 - 01/2018
3	Infections 10/2021 - 11/2008
3	Fibrosis (Cirrhosis) 04/2020 - 01/2016
3	Cognitive Dysfunction 03/2020 - 01/2017
3	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2020 - 03/2017
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2022
2	COVID-19 10/2021 - 04/2020
2	Weight Gain 03/2021 - 01/2021
2	Glucose Intolerance 01/2021 - 07/2015
2	Non-alcoholic Fatty Liver Disease 09/2019 - 03/2005
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 01/2013
2	Hyperglycemia 01/2017 - 01/2013
1	Weight Loss (Weight Reduction) 06/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Glucose Metabolism Disorders 01/2022
1	Glioma (Gliomas) 01/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Erectile Dysfunction 01/2022
1	Carcinogenesis 04/2021
1	Hepatocellular Carcinoma (Hepatoma) 04/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Exanthema (Rash) 01/2021
1	Colitis 04/2020

Drug/Important Bio-Agent (IBA)

13	Insulin (Novolin)FDA Link 01/2022 - 03/2005
12	BerberineIBA 04/2022 - 02/2015
12	Proteins (Proteins, Gene)FDA Link 04/2022 - 07/2010
11	Glucose (Dextrose)FDA LinkGeneric 03/2021 - 11/2009
8	LipidsIBA 09/2019 - 03/2005
6	jiao tai wanIBA 03/2020 - 01/2013
5	Blood Glucose (Blood Sugar)IBA 01/2022 - 03/2005
3	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2016
3	Therapeutic UsesIBA 01/2022 - 12/2013
3	Streptozocin (Streptozotocin)FDA Link 01/2022 - 08/2011
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
3	Nonesterified Fatty Acids (NEFA)IBA 01/2019 - 11/2009
3	isoquinolineIBA 01/2018 - 02/2016
3	AlkaloidsIBA 01/2018 - 02/2016
3	jiaotaiIBA 12/2017 - 08/2011
3	bushen tongmaiIBA 08/2010 - 03/2010
2	CateninsIBA 04/2022 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2021
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2022 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 03/2020 - 03/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 02/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 08/2018
2	dihydroberberineIBA 02/2015 - 11/2009
2	Triglycerides (Triacylglycerol)IBA 08/2011 - 03/2005
2	EnzymesIBA 08/2011 - 03/2005
2	Messenger RNA (mRNA)IBA 08/2010 - 07/2010
1	PolymersIBA 06/2022
1	MetalsIBA 06/2022
1	Trastuzumab (Herceptin)FDA Link 04/2022
1	Monoclonal AntibodiesIBA 04/2022
1	Hepatocyte Nuclear FactorsIBA 04/2022
1	6-methyladenineIBA 01/2022
1	formononetinIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Circular RNAIBA 01/2022
1	Small Nucleolar RNA (snoRNA)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Carbon MonoxideIBA 01/2022
1	superoxide dismutase 2IBA 01/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022
1	Propofol (Diprivan)FDA LinkGeneric 01/2022
1	N-methyladenosineIBA 01/2022
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 10/2021
1	Immunoglobulin M (IgM)IBA 10/2021
1	Neutralizing AntibodiesIBA 10/2021
1	AntibodiesIBA 10/2021
1	celastrolIBA 01/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021
1	TriterpenesIBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	Peptides (Polypeptides)IBA 12/2020
1	sym-trinitrobenzeneIBA 04/2020
1	Sulfonic AcidsIBA 04/2020
1	CollagenIBA 04/2020
1	Fibronectins (Fibronectin)IBA 04/2020
1	Hydroxyproline (4 Hydroxyproline)IBA 04/2020
1	Small Cytoplasmic RNAIBA 04/2020
1	NF-kappa B (NF-kB)IBA 02/2020
1	phillyrinIBA 02/2020

Therapy/Procedure

3	Therapeutics 04/2022 - 01/2016
3	Immunotherapy 12/2020 - 01/2020
1	Transplantation 04/2022
1	Aftercare (After-Treatment) 01/2022